UniSa - IRIS Institutional Research Information System

MAROTTA, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.958
NA - Nord America 1.128
SA - Sud America 965
EU - Europa 600
Continente sconosciuto - Info sul continente non disponibili 74
AF - Africa 60
OC - Oceania 3
Totale 8.788
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 4.523
US - Stati Uniti d'America 1.033
BR - Brasile 725
SG - Singapore 504
VN - Vietnam 457
IT - Italia 382
CN - Cina 235
AR - Argentina 91
FR - Francia 61
ID - Indonesia 53
BD - Bangladesh 46
EC - Ecuador 37
MX - Messico 36
PY - Paraguay 33
CO - Colombia 32
IN - India 31
CA - Canada 28
DE - Germania 22
GB - Regno Unito 19
UA - Ucraina 18
CL - Cile 17
RU - Federazione Russa 17
TR - Turchia 17
IQ - Iraq 16
KR - Corea 16
ZA - Sudafrica 13
PL - Polonia 12
VE - Venezuela 12
MA - Marocco 11
EG - Egitto 10
JP - Giappone 10
UY - Uruguay 10
ES - Italia 8
KE - Kenya 8
NL - Olanda 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
IE - Irlanda 6
LT - Lituania 6
PE - Perù 6
AL - Albania 5
JM - Giamaica 5
PH - Filippine 5
PK - Pakistan 5
UZ - Uzbekistan 5
AT - Austria 4
AZ - Azerbaigian 4
MY - Malesia 4
RS - Serbia 4
SA - Arabia Saudita 4
SE - Svezia 4
DZ - Algeria 3
FI - Finlandia 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
JO - Giordania 3
PA - Panama 3
SV - El Salvador 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
HN - Honduras 2
HR - Croazia 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
Totale 8.710
Salva come PNG Salva come JPEG
Città #
Hong Kong 4.516
San Jose 304
Milan 214
Singapore 177
Ho Chi Minh City 174
Dallas 145
Hanoi 103
Ashburn 99
Beijing 82
Council Bluffs 72
Rome 69
São Paulo 67
Lauterbourg 52
Santa Clara 38
Rio de Janeiro 29
Da Nang 25
Haiphong 25
Figino 24
New York 20
Los Angeles 19
Mexico City 19
Curitiba 17
Asunción 16
Boardman 16
Naples 15
Seoul 14
Thái Bình 14
Porto Alegre 13
Buffalo 12
Quito 12
Brasília 11
Houston 11
Ribeirão Preto 11
Woodbridge 11
Biên Hòa 10
Guayaquil 10
Ninh Bình 10
Salvador 10
Santo André 10
Phủ Lý 9
Santiago 9
Tokyo 9
Ann Arbor 8
Buenos Aires 8
Guarulhos 8
Montevideo 8
Orem 8
Toronto 8
Cairo 7
Campinas 7
Frankfurt am Main 7
Hortolândia 7
Jacksonville 7
Jakarta 7
Manaus 7
Medellín 7
Memphis 7
Munich 7
Turin 7
Baghdad 6
Belo Horizonte 6
Bắc Giang 6
Caxias do Sul 6
Chandler 6
Cuiabá 6
Hải Dương 6
Johannesburg 6
Maceió 6
Nairobi 6
Piracicaba 6
Recife 6
Volta Redonda 6
Warsaw 6
Bắc Ninh 5
Canoas 5
Charlotte 5
Coimbatore 5
Dublin 5
Izmir 5
Kyiv 5
Montreal 5
Nha Trang 5
Nuremberg 5
Phoenix 5
Poplar 5
San José 5
San Juan 5
Santiago de Cali 5
Seattle 5
Sumaré 5
Taiyuan 5
Tashkent 5
Araçatuba 4
Baku 4
Bauru 4
Caracas 4
Chicago 4
Duque de Caxias 4
Feira de Santana 4
Fisciano 4
Totale 6.859
Salva come PNG Salva come JPEG
Nome #
Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer 729
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 494
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. 405
The combined use of biological investigations, bio chromatographic and in silico methods to solve the puzzle of badge and its derivative's toxicity 333
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy 329
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer 329
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients 327
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: A comparative study 280
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present 279
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules 256
Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge 216
BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma 211
GH provocative tests stimulate the growth in children with idiopathic short stature 189
Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome 166
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life 150
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm 144
TSH modulation in advanced differentiated thyroid cancer: a continuous walk on the tightrope between prognostic stratification, adverse events, and levothyroxine bioavailability 142
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours 130
Fibrous Variant of Hashimoto’s Thyroiditis as a Diagnostic Pitfall in Thyroid Pathology 122
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review 115
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins 114
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 114
Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate 108
Targeted therapy with kinase inhibitors in aggressive endocrine tumors 106
Benign thyroid nodules with RAS mutation grow faster 102
Fathoming the link between anthropogenic chemical contamination and thyroid cancer 97
Chromogranin a as circulating marker for diagnosis and management of neuroendocrine neoplasms: More flaws than fame 96
Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management 95
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome 93
Editorial: Papillary thyroid cancer: prognostic factors and risk assessment 89
Are RET/PTC Rearrangements in Benign Thyroid Nodules of Biological Significance? 87
Inibitori multichinasici nel trattamento del carcinoma differenziato tiroideo iodio-refrattario 87
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib 87
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib (Endocrine, (2017), 57, 3, (539-543), 10.1007/s12020-016-1200-6) 86
Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases 86
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 84
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 84
Application of molecular biology of differentiated thyroid cancer for clinical prognostication 80
Total Thyroidectomy with Harmonic Scalpel Combined with Gelatin Thrombin Hemostatic: A Focus on the Elderly Population—A Multicentric Study 78
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. 77
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 74
Supplements in Oncology: Uses, Hurdles, Guidance, and Future Perspectives 74
Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells 73
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint 72
Radioiodide induces apoptosis in human thyroid tissue in culture 72
BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma 72
BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay 71
Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion 71
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 70
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application 69
Role of nutritional therapy on dietary habits and glycemic control in insulin-treated kidney transplant patients with diabetes 68
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas 67
Growing thyroid nodules with benign histology and RET rearrangement 67
The evolving field of kinase inhibitors in thyroid cancer 64
Unintentional recurrent laryngeal nerve injuries following thyroidectomy: Is it the surgeon who pays the bill? 61
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication 59
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 58
Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells 58
Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer 57
Limitations of Chromogranin A in clinical practice 54
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 54
High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements 53
Hepatic arterial embolization in patients with neuroendocrine tumors 48
First-line lenvatinib and sorafenib in RR-DTC from a shared real-life context 37
La diagnostica molecolare del nodulo tiroideo 36
Beyond the Genome: Can Epigenetics Forecast Therapeutic Success in Graves’ Disease and Thyroid Eye Disease? 15
Pathophysiology and treatment of exercise-associated hyponatremia 8
Somatic genomic profiling reveals clinically relevant heterogeneity in RAS-mutant sporadic medullary thyroid carcinoma 8
Modulation of chemokine secretion and oxidative stress in vitro in thyroid cells after exposure to thiocyanate, nitrate, or perchlorate 2
Totale 8.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.764
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 1 0 0 0 0 0 1 1 1 3
2022/202312 1 0 0 1 2 4 0 0 4 0 0 0
2023/20246 2 0 0 0 0 1 0 0 0 1 0 2
2024/20258 0 0 0 2 1 1 1 1 1 0 0 1
2025/20268.535 586 2.769 2.215 1.004 335 101 259 203 193 402 124 344
2026/2027180 93 87 0 0 0 0 0 0 0 0 0 0
Totale 8.788